DLC Recognizes Incoming Congressional Diabetes Caucus Co-Chair

Media Contact: media@diabetesleadership.org  

FOR IMMEDIATE RELEASE: December 21, 2022

Diabetes Leadership Council Recognizes

Incoming Congressional Diabetes Caucus Co-Chair

WASHINGTON - The Diabetes Leadership Council (DLC), a diabetes and health care reform advocacy organization advancing patient-centered policies at the local, state, and federal levels, today issued the following statement: "We are thrilled to hear that the Congressional Diabetes Caucus has announced a new House co-chair and look forward to working more closely with Congressman Bilirakis in his new role.  

“As a leading voice for over 37 million Americans living with diabetes, we continue to challenge and implore Congress to less talk and more action. With a full leadership suite in place, we are hopeful that the largest caucus in Congress can now to create meaningful change for our community. We invite and welcome an opportunity to engage Congressman Bilirakis as we have Congresswoman DeGette, and Senators Collins and Shaheen on the needs of people with diabetes including insulin affordability, treatment and management options and technology access, as well as emerging therapies for those not yet diagnosed.”


DLC is a 501(c)(3) patient advocacy organization comprised of individuals who combine their passion for advocacy with decades of diabetes experience and leadership to advance patient-first policies at the local, state, and national levels. Our members – all former leaders of national diabetes organizations – engage policymakers, and public and private sector influencers to call attention to the diabetes epidemic and provide a voice for 37 million Americans living with the disease.